UBS Group’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11K Sell
2,544
-6,016
-70% -$25.9K ﹤0.01% 7493
2025
Q1
$25.4K Sell
8,560
-5,385
-39% -$16K ﹤0.01% 6759
2024
Q4
$82.6K Buy
13,945
+13,706
+5,735% +$81.1K ﹤0.01% 5769
2024
Q3
$652 Buy
+239
New +$652 ﹤0.01% 7636
2024
Q2
Sell
-2
Closed -$4 8700
2024
Q1
$4 Buy
+2
New +$4 ﹤0.01% 7982
2023
Q3
Sell
-5,010
Closed -$19.4K 8623
2023
Q2
$19.4K Buy
5,010
+1,801
+56% +$6.99K ﹤0.01% 5811
2023
Q1
$24K Buy
+3,209
New +$24K ﹤0.01% 5863
2022
Q4
Sell
-392
Closed -$8K 9757
2022
Q3
$8K Buy
+392
New +$8K ﹤0.01% 7639
2022
Q2
Sell
-114
Closed -$6K 9648
2022
Q1
$6K Sell
114
-204
-64% -$10.7K ﹤0.01% 7928
2021
Q4
$13K Buy
+318
New +$13K ﹤0.01% 7346
2021
Q2
Sell
-231
Closed -$25K 8535
2021
Q1
$25K Buy
231
+159
+221% +$17.2K ﹤0.01% 6157
2020
Q4
$7K Sell
72
-22
-23% -$2.14K ﹤0.01% 6673
2020
Q3
$11K Buy
94
+71
+309% +$8.31K ﹤0.01% 5904
2020
Q2
$4K Buy
+23
New +$4K ﹤0.01% 6606
2020
Q1
Sell
-56
Closed -$12K 7185
2019
Q4
$12K Sell
56
-41
-42% -$8.79K ﹤0.01% 6115
2019
Q3
$18K Buy
+97
New +$18K ﹤0.01% 5839
2019
Q2
Sell
-234
Closed -$66K 7111
2019
Q1
$66K Buy
+234
New +$66K ﹤0.01% 4551
2018
Q3
Sell
-41
Closed -$13K 7147
2018
Q2
$13K Buy
41
+12
+41% +$3.81K ﹤0.01% 6075
2018
Q1
$28K Buy
29
+5
+21% +$4.83K ﹤0.01% 5289
2017
Q4
$5K Buy
24
+15
+167% +$3.13K ﹤0.01% 6411
2017
Q3
$3K Buy
+9
New +$3K ﹤0.01% 6475
2016
Q4
Sell
-5
Closed -$7K 6876
2016
Q3
$7K Sell
5
-1
-17% -$1.4K ﹤0.01% 6067
2016
Q2
$11K Buy
+6
New +$11K ﹤0.01% 5839
2016
Q1
Sell
-8
Closed -$19K 6828
2015
Q4
$19K Sell
8
-17
-68% -$40.4K ﹤0.01% 5606
2015
Q3
$61K Buy
+25
New +$61K ﹤0.01% 4560